Chemical Structure : TPA023
CAS No.: 252977-51-8
Catalog No.: PC-62769Not For Human Use, Lab Use Only.
TPA023 is a potent, α2/α3 subtype-selective, and oral GABAA receptor agonist with Kd of 0.92, 1.05 and 0.58 nM for α1-, α2-, α3-, and α5-containing human receptors.
| Packing | Price | Stock | Quantity |
|---|---|---|---|
| 5 mg | $98 | In stock | |
| 10 mg | $148 | In stock | |
| 25 mg | $258 | In stock | |
| 50 mg | Get quote | ||
| 100 mg | Get quote |
Bulk size, bulk discount!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
TPA023 (MK-0777) is a potent, α2/α3 subtype-selective, and oral GABAA receptor agonist with Kd of 0.92, 1.05 and 0.58 nM for α1-, α2-, α3-, and α5-containing human receptors.
TPA023 (MK-0777) shows much lower (50- to 2000-fold) affinities for α4 and α6 subtypes (Ki= 60 and 418 nM, respectively).
TPA023 (MK-0777) demonstrates anxiolytic-like efficacy and anticonvulsant activity in mouse pentylenetetrazole seizure model.
| M.Wt | 395.442 | |
| Formula | C20H22FN7O | |
| Appearance | Solid | |
| Storage |
|
|
| Solubility |
10 mM in DMSO |
|
| Chemical Name/SMILES |
7-(1,1-Dimethylethyl)-6-(2-ethyl-2H-1,2,4-triazol-3-ylmethoxy)-3-(2-fluorophenyl)-1,2,4-triazolo[4,3-b]pyridazine |
|
1. Atack JR, et al. J Pharmacol Exp Ther. 2010 Jan;332(1):17-25.
2. de Haas SL, et al. J Psychopharmacol. 2007 Jun;21(4):374-83.
3. Carling RW, et al. J Med Chem. 2005 Nov 17;48(23):7089-92.
4. Atack JR, et al. J Pharmacol Exp Ther. 2006 Jan;316(1):410-22.

Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright